A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 Diabetes

Mise à jour : Il y a 4 ans
Référence : NCT01513590

Femme et Homme

Extrait

This trial is conducted in Africa, Asia and Europe. The aim of the trial is to compare the efficacy and safety of insulin degludec/insulin aspart and BIAsp 30 (biphasic insulin aspart 30) in insulin naïve subjects with type 2 diabetes.


Critère d'inclusion

  • diabetes ,Diabetes Mellitus, Type 2


Liens